Melanie C. Smitt
- Oncology top 2%
- Cancer Research top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Pathology and Forensic Medicine top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Ian E. KropAntonio González-Martı́nHans WildiersPatricia LoRussoJean-Marc FerreroSung‐Bae KimRobert W. CarlsonStefanie S. Jeffrey
- Topics
- Breast Cancer Treatment Studies (19 papers)HER2/EGFR in Cancer Research (14 papers)Breast Lesions and Carcinomas (9 papers)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Melanie C. Smitt
42 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 1.4k
- Cancer Research 897
- Radiology, Nuclear Medicine and Imaging 784
- Pathology and Forensic Medicine 656
- Pulmonary and Respiratory Medicine 532
Countries citing papers authored by Melanie C. Smitt
This map shows the geographic impact of Melanie C. Smitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie C. Smitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie C. Smitt more than expected).
Fields of papers citing papers by Melanie C. Smitt
This network shows the impact of papers produced by Melanie C. Smitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie C. Smitt. The network helps show where Melanie C. Smitt may publish in the future.
Co-authorship network of co-authors of Melanie C. Smitt
This figure shows the co-authorship network connecting the top 25 collaborators of Melanie C. Smitt. A scholar is included among the top collaborators of Melanie C. Smitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie C. Smitt. Melanie C. Smitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trialbreakdown → | 371 |
| 2 | 17 | |
| 3 | Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trialbreakdown → | 512 |
| 4 | 91 | |
| 5 | 58 | |
| 6 | 91 | |
| 7 | 13 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 125 | |
| 11 | 2 | |
| 12 | 3 | |
| 13 | 68 | |
| 14 | 8 | |
| 15 | 27 | |
| 16 | 37 | |
| 17 | 44 | |
| 18 | 326 | |
| 19 | 19 | |
| 20 | 82 |
About Melanie C. Smitt
Melanie C. Smitt is a scholar working on Cancer Research, Otorhinolaryngology and Radiation, having authored 45 papers that have together received 2.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), HER2/EGFR in Cancer Research (14 papers) and Breast Lesions and Carcinomas (9 papers). The work is most often cited by research in Cancer Research (897 citations), Oncology (1.4k citations) and Pathology and Forensic Medicine (656 citations). Melanie C. Smitt has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Ian E. Krop, Antonio González-Martı́n, Hans Wildiers, Patricia LoRusso, Jean-Marc Ferrero, Sung‐Bae Kim, Robert W. Carlson, Stefanie S. Jeffrey, Kent W. Nowels and Ron Yu. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.